INTERNATIONAL PATENT: RIGERNA THERAPEUTICS (BEIJING) CO., LTD., 北京炫景瑞医药科技有限公司 FILES APPLICATION FOR "KIDNEY-TARGETING DOUBLE-STRANDED OLIGONUCLEOTIDE CONJUGATE AND USE THEREOF"

Posted On: 2025-11-09

GENEVA, Nov. 9 -- RIGERNA THERAPEUTICS (BEIJING) CO., LTD. (Room 409-316 (Cluster Registration), Floor 4, Building 1, No.38 Yongda Road, Daxing Biomedical Industry Base, Zhongguancun Science And Technology ParkDaxing District, Beijing 102629), 北京炫景瑞医药科技有限公司 (中国北京市大兴区中关村科技园区大兴生物医药产业基地永大路38号1幢4层409-316室（集群注册）) filed a patent application (PCT/CN2025/089793) for "KIDNEY-TARGETING DOUBLE-STRANDE...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: RIGERNA THERAPEUTICS (BEIJING) CO., LTD., 北京炫景瑞医药科技有限公司 FILES APPLICATION FOR "KIDNEY-TARGETING DOUBLE-STRANDED OLIGONUCLEOTIDE CONJUGATE AND USE THEREOF"